Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis.
<h4>Aims</h4>To compare the baseline cardiovascular characteristics of immunoglobulin light-chain (AL) and amyloid transthyretin (ATTR) cardiac amyloidosis (CA) and to investigate patients' contemporary cardiac outcomes.<h4>Methods</h4>Single-center analysis of clinical,...
Guardado en:
Autores principales: | Osnat Itzhaki Ben Zadok, Mordehay Vaturi, Iuliana Vaxman, Zaza Iakobishvili, Noa Rhurman-Shahar, Ran Kornowski, Ashraf Hamdan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec6cc53fbda64369b6e914aa9b515cb7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Sebastiaan HC Klaassen, et al.
Publicado: (2020) -
Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina
por: Maria S. Saez, et al.
Publicado: (2021) -
Light-chain cardiac amyloidosis with neuropathy: a case report
por: Xu ZW, et al.
Publicado: (2015) -
Characterization and long-term outcomes of patients with myocarditis: a retrospective observational study
por: Shelly Meron Grossman, et al.
Publicado: (2021) -
Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study
por: Guido Primiano, et al.
Publicado: (2021)